Company intelligence / Profile preview

Enantia

Barcelona, Catalonia, Spainenantia.com ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

Enantia specializes in chemical research and process development with strengths in asymmetric chemistry, cocrystallization technologies, medicinal chemistry support, solid-state R&D, and custom synthesis. The company acts as a CRO serving the pharma/biotech sectors from early discovery to process scale-up. It also develops internal research programs that may be licensed out but does not itself advance drugs through clinical trials. Recent activities include GMP production of cannabinoids like CBD at kilo scale.

Therapeutic areas: OtherNeurology
Modalities: Small moleculeCannabinoids (as small molecules)Organic synthesis products
Industry: Drug Discovery Services

Drug pipeline

1 asset

ertugliflozin

Commercial

Indications: Type 2 diabetes mellitus

Partnerships

Esteve/Mundipharma-Purdue partnership involving an innovative cocrystal developed by Enantia with Esteve R&D.Collaboration with ALBA Synchrotron light facility since 2014 for advanced crystal structure characterization.

Beyond the preview

Go deeper on Enantia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enantia.

Explore the full profile